Etanercept in axial spondyloarthritis – treatment efficacy

The beginning of the 21st century was marked by a simultaneous changes in view on pathogenesis, diagnostics and treatment of axial spondyloarthritis (axSpA). Anti-TNFα inhibitors were the first biologics prescribed in axSpA. 20 year after the biological treatment was first prescribed we have enough...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	I. Z. Gaydukova, O. V. Inamova, R. R. Samigullina, A. L. Chudinov, A. S. Bychkova
Materialtyp:	Artigo
Språk:	Russo
Utgiven:	IMA PRESS LLC 2022-03-01
Serie:	Научно-практическая ревматология
Ämnen:	axial spondyloarthritis non-radiographic axspa ankylosing spondylitis etanercept tnfα inhibitors treatment efficacy
Länkar:	https://rsp.mediar-press.net/rsp/article/view/3113
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!